5-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)-6,8,8-trimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one
C26H26O6 — CID 162849319
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)-6,8,8-trimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one
5-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)-6,8,8-trimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one (PubChem CID 162849319) has the molecular formula C26H26O6 and a molecular weight of 434.49 g/mol. Its IUPAC name is 5-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)-6,8,8-trimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one.
Molecular Properties
| Compound Name | 5-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)-6,8,8-trimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one |
|---|---|
| PubChem CID | 162849319 |
| Molecular Formula | C26H26O6 |
| Molecular Weight | 434.49 g/mol |
| Exact Mass | 434.17 |
| IUPAC Name | 5-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)-6,8,8-trimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one |
| SMILES | Cc1c(O)c2c(c3c1OC(C)(C)C=C3)OCC(c1ccc(O)c3c1OC(C)(C)C=C3)C2=O |
| InChI | InChI=1S/C26H26O6/c1-13-20(28)19-21(29)17(12-30-24(19)16-9-11-25(2,3)31-22(13)16)14-6-7-18(27)15-8-10-26(4,5)32-23(14)15/h6-11,17,27-28H,12H2,1-5H3 |
| InChIKey | PSTQKUQNSTXUGU-UHFFFAOYSA-N |
| XLogP | 5.13 |
| TPSA | 85.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.49 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162849319 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.